Third-Party Risk Management refers to the process of identifying, assessing, and controlling potential risks associated with external parties involved in a clinical research project. These third parties may include contract research organizations, suppliers, vendors, or any other entities that provide services or resources to the study.
This management approach involves implementing strategies to mitigate risks that could impact the integrity, quality, or timeline of the research. It typically includes due diligence, ongoing monitoring, and establishing clear communication channels with third-party partners to ensure compliance with regulatory requirements and study protocols.
Third-Party Risk Management is crucial in clinical research because it helps maintain the integrity and reliability of study data. By effectively managing risks associated with external partners, researchers can ensure compliance with regulatory standards and protect the safety of study participants.
This approach is also important for maintaining the reputation of research institutions and sponsors. Proper risk management can prevent delays, cost overruns, and potential legal issues that may arise from inadequate oversight of third-party activities in clinical trials.
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
Copyright @ 2026 Axcellant